Di Nuzzo Private Wealth, Inc. Annovis Bio, Inc. Put Options Transaction History
Di Nuzzo Private Wealth, Inc.
- $658 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ANVS
# of Institutions
55Shares Held
2.06MCall Options Held
88.1KPut Options Held
188K-
Vanguard Group Inc Valley Forge, PA648KShares$1.68 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA183KShares$474,7130.0% of portfolio
-
Two Sigma Investments, LP New York, NY166KShares$430,5070.0% of portfolio
-
Ubs Group Ag161KShares$416,6680.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA128KShares$330,7550.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $21.1M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...